Intrinsiqs

Is Neumora Therapeutics, Inc. Common Stock overvalued?

Neumora Therapeutics, Inc. Common Stock (NMRA) — key valuation metrics and fundamentals.

No verdict
Price
$0.69
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$128.2M
Dividend yield
0.0%
Return on equity
-242.3%
Sector
Healthcare

See the full interactive analysis →

Fair value compares NMRA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.